DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Swain SM, Kim SB, Cortes J. et al.
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.

Lancet Oncol 2013;
14: 461-471

Download Bibliographical Data

Search in:
Access: